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Regulatory agencies have enforced allergen labelling
rules for food ingredients on pre-packed food. HACCP
procedures driven on by food manufacturers reveals that
possible cross-contaminations of their products cannot
be absolutely discarded or checked. As a result and
because allergen absence cannot be accurately warranted
in most food industry, numerous warning mentions on
pre-packed foods appeared to inform allergic consumers
of potential cross contaminations even if levels are very
low. For Allergic consumers, accessibility to food is
clearly restricted.
In a practical view, the Unit of Allergology in Angers
Hospital (France) has developed an oral reintroduction
protocol of low doses of allergens to evaluate the sensi-
tivity of allergic patients. It appeared that most of the
patients tolerate low amount (few mg) of allergen and
would support the consumption of product contami-
nated by traces of allergen.
Based on these facts, the French competitiveness clus-
ter “Pôle Enfant” gathered four food manufacturers (pas-
try, meat, milk products: BRIOCHE PASQUIER,
CHARAL, LACTALIS, SADAC), ATLANGENE
®-SILLI-
KER specialized in food analysis, ten university hospitals
and hospitals, 3 academic laboratories (INRA, CNRS,
and AUDENCIA), and an association of French allergic
consumers (AFPRAL) to construct the “MANOE pro-
ject”. This project funded by the regional council of
Pays de la Loire aims to develop food products designed
for the general population which would be tolerated by
children allergic to peanut, egg, milk or wheat. In a
large multicentric clinical trial, 400 allergic children will
be submitted to the standardized reintroduction proto-
col. The acceptance and the usefulness of these new
products by allergic children and their parents will be
evaluated.
In the context where thresholds values for allergen
labelling rules are in discussion all around the world, this
integrated project will provide a practical insight on how
food companies will deal with thresholds, if the analytical
methods are good enough to guaranty these levels, and
how the patient will use this new information.
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